Abstract Submission

Since ISSHP 2021 changed the format to Virtual On-demand Conference,
please kindly be informed that the presentations will be video session.
Your presentation data with the narration will be posted on the virtual
conference site instead of giving a presentation in real time.

Abstract Submission Deadline

12:00 April 30 (Fri.) [Japanese Standard Time]

Extend by 12:00 May 31 (Mon.) [Japanese Standard Time]

Final Extension only for poster presentation!
By 12:00 June 30 (Wed.) [Japanese Standard Time]

Abstract submission is now close.
Thank you for your abstract submission.

*Please kindly be informed that all abstracts submitted during final extension will be automatically poster presentation.

Abstract Submission Guideline
(Oral ⁄ Poster Presentation)

  1. Abstracts should be prepared in accordance with the instructions below and submitted through the online system.
    Abstracts should comply with the editing instructions.
  2. Original scientific material is welcome, and preference is given to recent findings not yet published on submission.
  3. Abstracts will be peer reviewed and evaluated by experts in one of the categories (topics) listed; they will be allocated for oral or poster presentation.
    Authors who do not wish to be considered for oral presentation are requested to indicate this when submitting.
    However, please note, that the Scientific Committee will make the final decision for the type of presentation.
  4. Presenting Authors are requested to register for the congress.
    Abstracts whose Presenting Author have not made attendance registration will be withdrawn.
  5. First Authors of all the submitted abstracts will receive a notice of acceptance (non-acceptance) as well as the type of presentation by e-mail during July 2021 (tentative).
    Please make sure to have inserted the correct E-mail Address of the First Author.
  6. Authors agree that their abstract will be published in the congress abstract book.
  7. Authors agree that their presentation video will be posted on the virtual on-demand conference website during the conference period.

For further information and assistance please contact Organizing Secretariat :

Abstract Editing Instructions
(Oral ⁄ Poster Presentation)


For review purposes, abstracts are classified according to the following list. Select only 1 topic on our submission form:

01 Basic Science
02 Biomarkers and risk factors
03 Endothelium ⁄ lipids ⁄ oxidative stress
04 Immunology
05 Placenta
06 Genetics
07 Translational research
08 Epidemiology
09 Preeclampsia
10 Gestational hypertension
11 Chronic hypertension
12 Cardiology
13 Nephrology
14 Maternal mortality & morbidity
15 Fetal mortality & morbidity
16 Fetal programming
17 Treatment ⁄ management ⁄ outcome
18 Thrombosis and treatment
19 Clinical trials
20 Global Health
21 Late maternal consequences of Preeclampsia
22 Others
  1. Abstracts must be submitted and presented in ENGLISH.
  2. Maximum length (Body of Abstract) shall be 250 words.
  3. Abstracts should be structured in at least three sections, clearly mentioned such as: Background ⁄ Objectives - Methods - Results (optional) - Conclusions.
  4. Do not indent spaces on the first line of each paragraph. No space should be inserted between paragraphs. Use international standards for scientific articles.
  5. Only standard abbreviations may be used without definition. Data must be given in units widely used in literature.
  6. Only essential references should be included and put in brackets at the end of the abstract: Numbers in the text may refer to them.
  7. Drugs must be identified by their generic names.
  8. A maximum of ten (10) Co-authors, including the First Author, are allowed per submission.
  9. You will automatically be assigned a submission ID at the time you submit, and will be asked to select a Password.
    With this ID and password, you can log into the submission site to reedit your submission until the deadline.


All Presenting Authors are asked to disclose any conflict of interest at the time of presentation ⁄ on posters for the benefit of conference delegates.
To this effect, a slide at the end or beginning of your presentation should contain a summary of conflict(s) of interest.

Young Investigators

By ISSHP definition, a person is defined as a “Young Investigator”,
and thereby eligible for Young Investigator Award who is:

  1. a primary contribution to research in the past four years
  2. in full-time postdoctoral training, residency, or fellowship, or enrolment in a formally approved training program leading to a degree (BA, BS, MD, PhD, MS, MPH, DVM)